-+ 0.00%
-+ 0.00%
-+ 0.00%

Terns Pharmaceuticals Amends Its Current Exclusive Option And License Agreement With Hansoh Healthtech

Benzinga·01/22/2026 21:45:25
Listen to the news

SEC Filing.